Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance.
J Clin Invest. 2020 Nov 2;130(11):6109-6123. doi: 10.1172/JCI135528.
J Clin Invest. 2020.
PMID: 33074246
Free PMC article.